1.0Livingston Internationalhttps://www.livingstonintl.comKelsey Cruzhttps://www.livingstonintl.com/author/kelsey-cruz/rich600338<blockquote class="wp-embedded-content" data-secret="af3AXjuQTX"><a href="https://www.livingstonintl.com/health-canada-updates-drug-establishment-licence-applications-good-manufacturing-practice-evidence-requirements-active-pharmaceutical-ingredients-api/">Health Canada Updates to drug establishment licence applications and good manufacturing practice evidence requirements for active pharmaceutical ingredients (API)</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.livingstonintl.com/health-canada-updates-drug-establishment-licence-applications-good-manufacturing-practice-evidence-requirements-active-pharmaceutical-ingredients-api/embed/#?secret=af3AXjuQTX" width="600" height="338" title="“Health Canada Updates to drug establishment licence applications and good manufacturing practice evidence requirements for active pharmaceutical ingredients (API)” — Livingston International" data-secret="af3AXjuQTX" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> Health Canada issued a notice to industry and is advising that on November 8, 2016, full implementation of the active pharmaceutical ingredients (API) program will begin. To facilitate achievement of full implementation, Health Canada is communicating the following information to the industry: Updated Table A and instructions for new and amending drug establishment licence (DEL)... Read more »https://cdn.livingstonintl.com/livingston-content/uploads/2022/09/12163235/2022-livingston-fb.jpg1200630